MCRB
Seres Therapeutics, Inc.Company with tickers: MCRB
CIK
1609809
CUSIP
81750R201
Shares Outstanding
9,683,934
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $358,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $21,265,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Research & Development | $13,195,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-20,907,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-19,913,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-2.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-2.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |